CytoDyn Inc (OTCMKTS:CYDY) Stock Continues to See Selling Pressure
CytoDyn Inc (OTCMKTS:CYDY) has been on the radars of many investors in recent times due to its work related to the development of the product leronlimab, which could be used for treating multiple conditions. Market Action: On Wednesday, CYDY stock moved down 6.47% at $1.3000 with more than 6.09 million shares, compared to its average volume of 2.17 million shares. The stock has moved within a range of $1.2700 –…